IRIS
CAMELA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.675
NA - Nord America 1.335
EU - Europa 1.307
SA - Sud America 218
AF - Africa 61
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 4.603
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.292
SG - Singapore 859
RU - Federazione Russa 757
CN - Cina 349
HK - Hong Kong 207
BR - Brasile 187
DE - Germania 156
IT - Italia 125
VN - Vietnam 86
IN - India 74
FR - Francia 50
NL - Olanda 48
GB - Regno Unito 42
KR - Corea 28
UA - Ucraina 28
CI - Costa d'Avorio 24
CA - Canada 21
FI - Finlandia 21
ZA - Sudafrica 17
PL - Polonia 14
MX - Messico 13
SE - Svezia 13
JP - Giappone 11
BG - Bulgaria 10
TR - Turchia 10
BD - Bangladesh 9
IE - Irlanda 9
AR - Argentina 8
EC - Ecuador 7
ES - Italia 7
ID - Indonesia 7
VE - Venezuela 6
LT - Lituania 5
RS - Serbia 5
JO - Giordania 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
LB - Libano 3
PE - Perù 3
RO - Romania 3
SN - Senegal 3
UZ - Uzbekistan 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
HN - Honduras 2
HU - Ungheria 2
IQ - Iraq 2
IR - Iran 2
MA - Marocco 2
NP - Nepal 2
PK - Pakistan 2
PY - Paraguay 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SD - Sudan 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 4.603
Salva come PNG Salva come JPEG
Città #
Singapore 387
Ashburn 206
Hong Kong 202
Moscow 177
Chandler 150
Hefei 126
Beijing 105
Santa Clara 97
Los Angeles 46
Ho Chi Minh City 36
Amsterdam 35
Lawrence 32
Napoli 31
Millbury 26
Seoul 25
São Paulo 23
Boston 22
Munich 22
Seattle 22
Naples 21
Buffalo 20
Düsseldorf 20
New York 19
Redondo Beach 19
Wilmington 19
Hanoi 18
Kochi 18
Washington 17
Dallas 16
Des Moines 16
Menlo Park 15
San Jose 15
Frankfurt am Main 13
Helsinki 13
Houston 13
Krefeld 12
Fairfield 11
Tokyo 11
Warsaw 11
Johannesburg 10
Brooklyn 9
Milan 9
Montreal 9
Pune 9
Sofia 9
Woodbridge 9
Phoenix 8
Rio de Janeiro 8
Chennai 7
Chicago 7
The Dalles 6
Ankara 5
Atlanta 5
Bhubaneswar 5
Council Bluffs 5
Falkenstein 5
Mexico City 5
Orem 5
Querétaro 5
San Francisco 5
Amman 4
Belo Horizonte 4
Brasília 4
Campinas 4
Fremont 4
Guangzhou 4
Haiphong 4
Kronberg 4
Lappeenranta 4
Lauterbourg 4
Nuremberg 4
Poplar 4
Portsmouth 4
Redwood City 4
Stockholm 4
Thái Bình 4
Turku 4
Afragola 3
Baku 3
Bucharest 3
Calgary 3
Columbus 3
Da Nang 3
Dakar 3
Denver 3
Dublin 3
Esslingen am Neckar 3
Gangnam-gu 3
Hyderabad 3
Jakarta 3
London 3
Palermo 3
Paris 3
Porto Alegre 3
Quito 3
Roccasecca 3
Rome 3
Rottweil 3
San Giuseppe Vesuviano 3
Segrate 3
Totale 2.369
Salva come PNG Salva come JPEG
Nome #
An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy- a new subtype? 153
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 150
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 148
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case 145
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma 124
A new dermoscopic pattern for chilblain-COVID-19–like skin lesions in adolescents 119
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 115
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 115
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab 110
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 109
Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient 108
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge 107
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 106
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 103
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 103
Erythrodermic Pityriasis Rubra Pilaris treatment: two case reports and literature review 103
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 101
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study 98
Hereditary Angioedema Type III, Recurrent Pregnancy Loss and Heterozygous MTHFR Mutation 98
Anti‐interleukin‐23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice 95
Risankizumab treatment in psoriasis patients who failed anti-IL17: a 52-week real-life study 95
Nail changes as manifestation of systemic disease in COVID‐19 infection 94
Dermatophytid evaluated by in vivo reflectance confocal microscopy: a new approach? 94
Teledermatology: a useful tool also after Covid-19 era? 92
Letter to the editor regarding article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610." 91
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period 90
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5" 90
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study 89
Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2-year period 87
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis? 86
Immune response to Covid‐19 mRNA vaccination in psoriasis patients undergoing treatment with biologics 86
A case of pediatric psoriasis successfully and rapidly treated with ixekizumab 84
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al 82
A case of erythrodermic psoriasis successfully treated with guselkumab 81
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation 79
A case of erythrodermic psoriasis successfully treated with apremilast 79
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge 75
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: results from an Italian single-centre retrospective study in a real-life setting 71
Reply to ‘New‐onset cutaneous lichen planus triggered by COVID‐19 vaccination’ by Merhy et al 71
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation 69
New frontiers in personalized medicine in psoriasis 68
Reply to "Where are the older adults? Age distribution of nail psoriasis-randomized clinical trials' participants: a systematic review" by Ricardo JW et al 66
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge 64
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series 63
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience 56
Giant basal cell carcinoma of the vulva successfully treated with Sonidegib 51
A Case of Adult-onset Facial Cutaneous Mastocytoma: Clinical and Dermoscopic Findings 48
Topical oil formulation of plant extracts and vitamins as effective treatment for stretch marks and xerosis—An observational longitudinal study 48
Treating psoriasis in the elderly: biologics and small molecules 48
Towards Personalized Medicine in Psoriasis: Current Progress 45
Paradoxical reactions to biologicals for psoriasis 40
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation 40
Reply to "Routine re-screening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: a single-center retrospective cohort study" 38
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? 34
Totale 4.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.733
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021125 0 0 0 0 0 0 2 45 62 8 8 0
2021/2022277 1 7 0 14 15 6 8 17 63 41 24 81
2022/2023454 37 35 15 17 39 56 49 64 65 36 32 9
2023/2024397 24 46 33 40 38 88 6 51 2 8 48 13
2024/20251.699 74 24 7 14 52 108 153 93 141 259 636 138
2025/20261.706 334 243 281 246 443 134 25 0 0 0 0 0
Totale 4.704